The condition of enlarged veins majorly seen in feet and legs is defined as Varicose Vein. It is caused by physiological condition, secretion changes, genetic disorders and high vital sign. Varicose Vein is generally found in women, obese population and people above age of 40 years. Hereditary factors and constant position for extended hours also results in this condition. Around 40% of the US population are affected by this disease and more than 30 million people in the country are having venous insufficiency.
The Global Varicose Vein Treatment Market was valued at USD 328.98 million in 2018 and is estimated to reach USD 448.62 million by 2023, growing at a CAGR of 6.4%. Some of the latest advances in varicose vein treatment technology include laser ablation systems, extreme-pulsed-mild therapy, incorporation of closure structures, radiofrequency systems, and ultrasound-guided structures.
View Sample Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/request-sample
Various advantages like less incisions, quicker recuperation prices, better achievement quotes, much less patient trauma, low adverse aspect consequences, advanced efficacy, and less post-operative headaches provided by the gadgets in the treatment are the principal factors driving the Varicose Veins market. Shift towards less-invasive treatment procedures, accessibility of advanced varicosity treatment devices, the burden of varicosity cases, rising patient compliance & liableness, growing health care expenditure, and rise in aging population are other factors that are fuelling the Varicose Vein treatment market.
On the flip side, the high prices associate with the treatment, shortage of skilled surgeons, fierce market competition and volatile reimbursement policies are some of the factors hindering the rapid growth of the market.
Read Full Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/
The full report of global varicose vein treatment market offers complete information about overall market size, share, trends and future developments. It also describes the global market based on the treatment, product, and regional analysis, along with competitive landscape.
On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation. Endovenous ablation segment accounted for the major share of the market and is likely to continue the same in the forecast period.
Based on type of products, the global market is segmented into ablation devices, venous closure products, and surgical products. Ablation devices dominated the market in the recent years and is anticipated to retain the same in the forecast period.
Based on region, the Global Varicose Vein Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is leading the global Varicose Vein Treatment Market. This can be attributed to variety of things such as advancement in technology that leads to advancements in infrastructure, continuous lifestyle changes, increasing awareness towards health and hygiene, increasing government funds, rising prevalence of unhealthy veins, high financial gain, and growing significance of aesthetics. In addition, favourable compensation policies, significantly among the US have significantly boosted the marketplace for in North America.
The Asia Pacific Varicose Vein Treatment Market is anticipated to grow with a double digit CAGR in the forecast period, which can be attributed to a surge in financial gain, improvement in health care infrastructure, and an increase in patient awareness regarding the advantage of seeking early treatment.
Customized Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/customize-report
The full report also provides the data related to leading companies in the world market. Some of the key players in the Varicose Vein Treatment Market include Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), and Merz Aesthetics (U.S.).
The increasing adoption of technological innovations in the manufacturing, distribution and use of gadgets in the varicose vein treatment offers lucrative growth opportunities for these market giants to capitalize the demand.
Scope of the report:
About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.
Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Media ContactCompany Name: Market Data ForecastContact Person: Abhishek ShuklaEmail: Send EmailPhone: +1-888-702-9626Address:2nd Floor, Lakeview Plaza, Kavuri Hills City: HyderabadState: TelanganaCountry: IndiaWebsite: https://www.marketdataforecast.com/